Abstract
This retrospective clinical analysis by Nockolds, et. al., demonstrates both the safety and efficacy of Biodesign in treatment of complex hernias. Grade III-IV hernias can be treated successfully with the Biodesign Hernia Graft.
Cook Biotech is now part of RTI Surgical.
See the press release about this acquisition for more information.